-+ 0.00%
-+ 0.00%
-+ 0.00%

Halozyme names James M. Daly as director

PUBT·10/02/2026 20:43:06
Listen to the news
Halozyme names James M. Daly as director
  • Halozyme Therapeutics named James M. Daly to its board, triggering an initial insider ownership filing dated Sept. 28, 2026.
  • The filing lists Daly as a director.
  • It reports no securities beneficially owned as of the filing date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001159036-26-000135), on October 02, 2026, and is solely responsible for the information contained therein.